Hansong Du
Overview
Explore the profile of Hansong Du including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen B, Sheng W, Wu Z, Ma B, Cao N, Li X, et al.
Int J Surg
. 2024 Mar;
110(6):3527-3535.
PMID: 38489557
Background: Currently, there is a lack of ideal risk prediction tools in the field of emergency general surgery (EGS). The American Association for the Surgery of Trauma recommends developing risk...
2.
Du K, Wang X, Li S, Ren J, Li R, Wang M, et al.
FEMS Microbiol Lett
. 2021 Dec;
368(21-24).
PMID: 34864963
Aiming to reveal the molecular mechanisms involved in right- and left-sided colorectal cancer (CRC) development, CRC gene expression data and a microorganism atlas were downloaded from The Cancer Genome Atlas...
3.
Du H, Yang J, Zhang Y
BMC Cancer
. 2020 Apr;
20(1):357.
PMID: 32345239
Background: This study aimed to investigate the efficacy and safety of cytokine-induced killer (CIK)/dendritic cell combined with CIK (DC-CIK) cell therapy in advanced gastrointestinal cancer (GIC). Methods: The PubMed, Cochrane...
4.
Zhang T, Chen W, Jiang X, Liu L, Wei K, Du H, et al.
Biosci Rep
. 2018 Nov;
39(1).
PMID: 30429232
The present study investigated the effects of Colchicine on gastric carcinoma (GC) cells and explored its possible mechanisms underlying such effects. The results of MTT and colony formation assays showed...
5.
Xu B, Wang Y, Yang J, Zhang Z, Zhang Y, Du H
Cancer Chemother Pharmacol
. 2016 Mar;
77(4):797-806.
PMID: 26931344
Purpose: In our previous study, we found that celecoxib, a kind of COX-2 inhibitor, led to cell apoptosis while up-regulating the expression of vascular endothelial growth factor (VEGF) in colorectal...
6.
Tian S, Chang W, Du H, Bai J, Sun Z, Zhang Q, et al.
Anticancer Drugs
. 2015 Jul;
26(9):964-73.
PMID: 26225471
It has been reported previously that celecoxib shows antitumor effects in many types of cancers. Here, we detected its effects on DLD-1 and SW480 (two human colon cancer cell lines)...
7.
Du H, Wang Y, Zhang Z, Yang J, Zhang J, Zhang Y
Cell Physiol Biochem
. 2015 Jul;
36(5):1821-34.
PMID: 26184741
Aims: To explore the explicit role of fibronectin (FN) isforms in atherosclerotic lesions and the underlying mechanisms. Methods And Results: Inducible stable expression was performed, and similar results were observed...
8.
Zhai R, Kan X, Wang B, Du H, Long Y, Wu H, et al.
Tumour Biol
. 2014 Aug;
35(11):11367-73.
PMID: 25119599
We aimed to study the post-translational regulation of CD151 by the microRNA miR-152. CD151 is highly expressed in gastric cancer (GC) and has been shown to accelerate GC by enhancing...
9.
Du H, Yao W, Fang M, Wu D
Mol Cell Biochem
. 2011 Jun;
357(1-2):415-22.
PMID: 21660463
In this study, in order to investigate the p53-independent function of p14ARF, we established p14ARF-inducible clones in the p53-deficient HCT cell line using the doxycycline-inducible expression system. A strong cell...
10.
Du H, Li W, Wang Y, Chen S, Zhang Y
Oncol Rep
. 2011 May;
26(2):495-502.
PMID: 21567098
Increasing evidence suggests that celecoxib, a COX-2 inhibitor with potent anticancer activity exerts its effects not only through COX-2, but also through COX-2-independent mechanisms. In the present study, we hypothesized...